TRACON Pharmaceuticals, Inc. (TCON) Financials
Stock symbol TCON is outdated, potentially delisted? Maybe it is available on other exchange?
TCON Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2024 | 7.4 million | 10.5 million |
| March 31, 2024 | 9.4 million | 11.1 million |
| Dec. 31, 2023 | 10.1 million | 10.9 million |
| Sept. 30, 2023 | 9.4 million | 12.5 million |
TCON Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2024 | -2.8 million | 339000 |
| March 31, 2024 | -2.5 million | 383000 |
| Dec. 31, 2023 | -522000 | 490000 |
| Sept. 30, 2023 | 15.1 million | 493000 |
TCON Net Income
No data available :(
TCON Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2024 | 6.3 million | - | - |
| March 31, 2024 | 7.9 million | - | - |
| Dec. 31, 2023 | 8.6 million | 732000 | 236000 |
| Sept. 30, 2023 | 7.8 million | 700000 | 1.0 million |
TCON Shares Outstanding
TCON Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2024 | - | 1.4 million | 1.6 million | - |
| March 31, 2024 | - | 1.9 million | 1.4 million | - |
| Dec. 31, 2023 | - | 1.5 million | 1.1 million | - |
| Sept. 30, 2023 | - | 2.3 million | 1.3 million | - |
TCON Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2024 | 55000 | - |
| March 31, 2024 | 100000 | 4000 |
| Dec. 31, 2023 | 3.0 million | 3000 |
| Sept. 30, 2023 | - | 4000 |
TCON
Price: $0.03
52 week price:
Earnings Per Share: 5.93 USD
P/E Ratio: 0.01
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 47100
Ebitda: 1.4 millionMarket Capitalization: 109725